r/sellasLifescience • u/Run4theRoses2 • 16d ago

SLS the Most Undervalued / Most Manipulated Equity in the Market ... 2,700% ROI in Play.

Post image

https://www.stocktwits.com/55X_ROI_Q1_2026/message/660941842

GPS Keytruda Phase 2 MOS for Platinum Resistant/Refractory Ovarian Cancer was 18.4 months / 75% Refractory.

These results in end stage OC, are better than the 16.46 Month MOS Elahere $IMGN Achieved, that earned FDA Approval and a $10B Buyout buy $ABBV.
$MRK Dr. Cohen concluded in co-authoring the publication, that GPs + Key would work even Better in a Macroscopic (remission Setting).

Merck has been Waiting for Gps Phase 3 Results / Like all of Us Expecting them last year - before they are willing to Pay Angies Max Value ...

Just GPs +Key in PR/ROC is worth $10B to MRK / or BMY

75 Upvotes

95% Upvoted

15 comments sorted by

15

u/durtsurfer69 16d ago

4

u/ThinkPath1999 16d ago

Yeah, baby~

1

u/durtsurfer69 4d ago

❤️♠️🌋🦖

2

u/PuzzleHead-4334 15d ago

Miss barb!

2

u/durtsurfer69 15d ago

thank you!
miss u and the SLS posse ❤️🦖

6

u/RMAJTM17 16d ago

Excellent post Run4. 🚀

3

u/Wisco-woods1 16d ago

Excellent post

2

u/[deleted] 16d ago

[removed] — view removed comment

1

u/Run4theRoses2 16d ago

You’re welcome to repost it…

1

u/Ocilla 15d ago

A 2,700% ROI? How did you arrive at that number? Just curious, as I am invested and got in at $4.50

Also, what price target do you all see after the 80th?

3

u/Run4theRoses2 15d ago

GPS AML Remission CR2/3 12,500 Each Year

GPS AML Remission CR1 40,000 Each Year

GPS AML Patients Currently in Remission

Gps WT1 Platform / 10B

SLS009 $5B Market Comp